Leal Therapeutics develops novel therapeutics for patients.
Leal Therapeutics has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in August 2026.
Leal Therapeutics's investors include Eli Lilly, Newpath Management, OrbiMed, Dementia Discovery Fund, Alexandria Venture Investments.
Leal Therapeutics is headquartered in Worcester, United States.
Leal Therapeutics develops novel therapeutics for patients.
Leal Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Leal Therapeutics — Funding & Investors." VCBacked, August 17, 2026, https://www.vcbacked.co/company/leal-therapeutics. Accessed September 13, 2026.
VCBacked. (2026). Leal Therapeutics — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/leal-therapeutics
{{cite web |title=Leal Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/leal-therapeutics |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated